SA
PBLS logo
Parabilis Medicines, Inc.(PBLS)
Closing price · checked 8:36 PM ETAbout this dataData status
$27.44▼-0.18 (-0.67%)
Extended:$27.44+0.00 (+0.00%)· 8:36 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Parabilis Medicines, Inc. (PBLS)

Financing Cash Flow

$1.14B

TTM · Period ending: · USD

PBLS logo

PBLS Financing Cash Flow

Latest reported$1.14B
PBLS Cash from Financing ($78.09M → $1.14B)
High-resolution chart · PNG

What is financing cash flow?

Cash from issuing/repaying debt and equity.

PBLS financing cash flow history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Parabilis Medicines, Inc. Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)Change
64,382,000−17.55%
78,085,000—

Frequently asked questions: PBLS financing cash flow

What is Parabilis Medicines, Inc. (PBLS)'s current financing cash flow?

Parabilis Medicines, Inc. (PBLS)'s latest reported financing cash flow (TTM) is $1.14B as of Sep 30, 2026. Cash from issuing/repaying debt and equity.

How much historical financing cash flow data is available for PBLS?

Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s financing cash flow, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare PBLS's financing cash flow to peers or set an alert?

You can open PBLS's financing cash flow in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PBLS delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.